Dr. Vincent Galan has practiced in the Atlanta area since 1988 and has held the distinguished position of Director of Pain Center at Southern Regional Medical Center in Riverdale, Georgia since 1990. Dr. Galan is board certified in Anesthesia and double boarded in Pain Medicine by both the American Academy of Pain Medicine (AAPM) as well as the American Board of Anesthesiology’s (ABA) Subspecialty Certification in Pain Management. Additionally, Dr. Galan has been contributed to the examination and test writing process for both of the aforementioned organizations.
Dr. Galan completed his pain fellowship at Downstate Medical Center – SUNY. He then continued on to Hermann Hospital, University of Texas, where he had the distinction to train as a visiting fellow with Dr. P. P. Raj, Professor of Anesthesia at the University of Texas and Director of its Pain Clinic. Dr. Raj is also a founder of the American Society of Regional Anesthesia and author of 7 books related to Acute and Chronic Pain. Dr. Raj has earned numerous awards and honors and is listed in the “Best Doctors in America” in Chronic Pain Management, contributed to over 100 articles, edited numerous editorials, and is the past Chief Executive Editor of Pain Digest and past Editor in Chief with MD Consult Pain Medicine. Dr. Raj retired as Professor of Anesthesiology and Co-Director of the International Pain Institute at Texas Tech University Health Sciences Center.
Dr. Galan is a past contributor to the international journal “Pain Digest” and a past medical reviewer for the publishing company Williams and Wilkins. He currently serves in the U.S. Advisory Board of Nasalfentanyl, a product for breakthrough Cancer Pain from Archimedes Pharmaceutical. Additionally, Dr. Galan has published many articles in regards to his research in various scholarly journals, including the following:
11th Congress of the European Association for Palliative Care, 7-10 May 2009, Vienna, Austria
- Fentanyl pectin nasal spray (FPNS) with PecSys® is rapid, effective and well tolerated in the treatment of breakthrough cancer pain (BTCP): a multicentre, placebo-controlled double-blind, two-phase crossover study. Russell Portenoy, Allen Burton, Mark Wallace, Richard Rauck, Vincent Galan, Donald Taylor
American Pain Society – 28th Annual Scientific Meeting, 6-9 May 2009, San Diego, CA
- A Multicentre, Placebo-Controlled, Double-Blind, Two-Phase Crossover Study of Fentanyl Pectin Nasal Spray (FPNS) with PecSys® in Breakthrough Cancer Pain (BTCP). Russell Portenoy, Donald Taylor, Mark Wallace, Richard Rauck, Vincent Galan, Allen Burton
The Journal of Palliative Medicine – 2009; Suppl. 38.
- Portenoy R, Burton A, Wallace M, Rauck R, Galan V, Taylor D. The efficacy, tolerability and onset of action of fentanyl pectin nasal spray (FPNS) with PecSys® in the treatment of breakthrough cancer pain (BTCP): a multicentre, placebo-controlled, double-blind, two-phase crossover study.
The Journal of Pain – 2009; 10(4):S36
- Wallace M, Portenoy R, Taylor D, Rauck R, Galan V, Burton A. Fentanyl Pectin Nasal Spray (FPNS) with PecSys®: efficacy, tolerability, and onset of action in the treatment of breakthrough cancer pain (BTCP).
The Journal of Supportive Oncology – 2010;8: 184-90
- Taylor D, Galan V, Weinstein SM et al. Fentanyl pectin nasal spray in breakthrough cancer pain.
Dr. Galan is a member of the American Society Interventional Pain Physicians, International Spinal Injection Society, American Society of Anesthesiology, International Anesthesia Research Society, Georgia Society of Anesthesiologists, as well as the American Society of Regional Anesthesia. Additionally, he has served in the members committee of the Association of Anesthesia Clinical Directors.
Dr. Galan’s areas of interest in interventional pain medicine include: spine-related disorders, sympathetic dystrophies, and cancer pain. His areas of expertise reside in minimally invasive spine surgery, cervical, thoracic & lumbar radiofrequency, spinal cord stimulators, discography, and other procedures used to diagnose or treat internal disc disruption, contained disc herniations, facet joint disease, complex regional pain syndrome (RSD) and neuropathies.
Dr. Galan is actively involved in investigational pharmaceutical studies where he can not only offer his patients some of the latest medications before they get to the market, but also help advance our knowledge of the treatment of pain.